How do I set a price alert for VIR?

To set a VIR price alert on Stock Alarm Pro, navigate to the VIR quote page, select "Set Alert," choose your trigger type (price target, % move, RSI level, MACD, or volume breakout), and set your delivery channel. Stock Alarm Pro supports instant push notifications, SMS, and automated phone call alerts.

Can I get phone call alerts for VIR?

Yes. Stock Alarm Pro provides real-time automated phone call alerts for VIR. Phone call alerts ensure you are immediately awakened or interrupted during critical volatility events, overnight earnings moves, or strict stop-loss levels when silent push notifications might be overlooked.

What types of alerts can I set for Vir Biotechnology Inc?

Stock Alarm Pro supports over 125 trigger types for VIR: price target alerts (above/below target), intraday percentage moves, RSI overbought/oversold levels, 50-day and 200-day moving average crossovers (golden cross / death cross), relative volume (RVOL) spikes, confirmed earnings date releases, and SEC Form-4 insider transaction filings.

How quickly will I be notified about VIR price changes?

VIR alerts are evaluated continuously in real-time against live market telemetry. Notifications are dispatched within sub-second latency via push notifications, SMS, or phone calls as soon as your trigger condition is met across regular, pre-market, and after-hours trading sessions.

Is Stock Alarm Pro free to use for VIR alerts?

Yes, Stock Alarm Pro offers a free tier that includes 3 active price alerts for VIR and other stocks. Full Pro membership is $20/month or $168/year with a 7-day free trial, unlocking unlimited alerts, phone call delivery, SMS, all 125+ technical indicators, institutional screeners, and real-time market telemetry across web, iOS, and Android.

Vir Biotechnology Inc (VIR) Price Alerts

Demo Sign up Log In

Vir Biotechnology, Inc.(VIR)

NASDAQClosing price · checked 7:04 AM ESTAbout this dataData status

$13.13▼-0.02 (-0.15%)

Pre-Market:$13.01-0.12 (-0.91%)

WatchlistChart Studio

VIR(VIR)

VIR

S&P 500, Nasdaq below the 50-day average

Market overview →Overview →

Explore More

VIR Financial Metrics

Explore 130+ historical metrics & ratios

Stock Comparison

Compare equities side by side

52-Week Highs Breakout

Stocks breaking to new annual highs

52-Week Lows Oversold

S&P 500 oversold value screener

Trending Momentum

Relative strength momentum leaders

Earnings Calendar

Upcoming earnings dates & reports

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.

VIR Fundamentals

Annual and trailing 12-month values

All metrics →All fundamentals →

VIR News

All news →

About

Vir Biotechnology is a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. Vir has assembled four technology platforms that are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. Its current development pipeline consists of product candidates targeting SARS-CoV-2, hepatitis B virus, influenza A, human immunodeficiency virus and tuberculosis.

Sector

Professional, Scientific, and Technical Services

Industry

Research and Development in Biotechnology

Website

www.vir.bio ↗

Leadership (12)

Brent SabatiniSenior Vice President, Principal Accounting Officer & Chief Accounting Officer

Toby MedarisExecutive Vice President & Chief Human Resources Officer

Carolyn WangSenior Vice President of Corporate Communications

Vanina De VerneuilExecutive Vice President, General Counsel & Corporate Secretary

Jeff CalcagnoExecutive Vice President & Chief Business Officer

Jennifer Eileen TowneExecutive Vice President & Chief Scientific Officer

Kiki PatelHead of Investor Relations

Maninder HoraExecutive Vice President & Chief Technical Operations Officer

Aziz SawafExecutive VP, CFO & Principal Financial Officer

Lawrence CoreyCo-Founder & Scientific Advisor

Louis J. PickerCo-Founder & Scientific Advisor

Marianne De BackerPresident, CEO & Director

About

Outlook

6 analystsBuy$20.00+52.3%

TrendUptrend17.4% above 50-day

Key Metrics

TTMAll charts →

Select a linked metric to explore its chart.

Market Cap$2.25B Revenue TTM$302.80M

Rev Growth FY26E+382.0%

Rev Growth YoY+1696.0%Price / Sales7.4x

P/E (TTM)—

Net Income TTM-$184.79M Free Cash Flow-$141.82M Gross Margin97.2%Operating Margin-69.8%Net Margin-61.0%Return on Equity-21.4%

Return on Assets-16.6%

Debt / Equity (MRQ)0.10 Current Ratio (MRQ)6.30 EPS TTM$-1.09

All VIR metrics →Financial statements →

Trading snapshot

Price & range

Prev Close

13.12

Open

13.22

Day Range12.94 – 13.43

12.94

13.43

52W Range5.32 – 14.38

5.32

14.38

86% of range

50-Day MA

11.19(+17.4%)

200-Day MA

9.75(+34.6%)

Volume & size

Avg Volume

2.0M

Valuation & risk

P/E (TTM)

-7.1x

Not profitable

EPS (TTM)

—

Div Yield (TTM)

No dividend

Beta

1.29

Market-like

Momentum

RSI (14)

63

Bullish momentum

Upcoming Events

EEarnings Report

In 102 days

Feb 22

Explore More

S&P 500 Sector Leaderboards

Fundamental Metric Rankings

VIR Fundamentals

VIR News

About

Leadership (12)

About

Upcoming Events

About

Leadership (12)

Outlook

Key Metrics

VIR Fundamentals